Noam Danenberg CEO N. Danenberg Holding Ltd noam@danenberg.co.il Experience CEO at N. Danenberg Holding (2000) Ltd) 2000 - Present (13 years) Investment Consulting Firm Consultant at Bonzai Holding Ltd. 2006-2012 (6 years) Investment consultant in the fields of Alternative energy technological solutions and commercial/residential real estate investment in Eastern Europe,. Chairman at Hawk Medical Technologies Ltd 2003-2012 (9 years) Chairman, in charge of fund raising, investors communications, company business strategy and large distributor and strategic partner accounts. Company engaged in design, develop, manufacture and market innovative medical / aesthetic device for tattoo removal purposes. Investment advisor at International Software Consulting Group Limited 2000-2012 (12 years) Investments advisor in the fields of CRM mix software & hardware solutions, medical devices. Chairman & CEO at Fitracks Inc 2004-2008 (4 years) Functioned as CEO and later chairman. Company engaged in designing, developing, manufacturing and selling CRM system comprising of software and foot measuring apparatus for the footwear industry. Company Advisor at Securities & Holding NV 1994-2000 (6 years) Investments advisor. Engaged in investment in the fields of residential and commercial real estate in Europe, CRM software, medical devices. Founder, buyer at I. C. & R. Ltd. 1993-1996 (3 years) Founder, in charge of purchasing and shipping scrap metals from sources in Europe and Africa. Founder, CEO at Aerodiam Europe 1989-1993 (4 years) Established and managed the company marketing stock management software for the diamond industry, Page1
recruited sales and support personnel and in charge of sales of large accounts. Languages English Hebrew (Professional working proficiency) (Native or bilingual proficiency) Skills & Expertise Fundraising Global tax planning Deal Maker m&a negotiations Entrepreneurship Strategic Partnerships Extensive investors network Tax Education Boston University Brussels Graduate Center (BUB) Master of Business Administration (MBA), Global Tax Planning, 1996-1997 Grade: Cum Laude european University Antwerp, Belgium Bachelor of Business Administration (BBA), Computer Science, 1989-1990 Honors and Awards Several registered patents in the aesthetic and electronic foot scanning device field Graduated Cum Laude at Boston University Page2
Noam Danenberg CEO N. Danenberg Holding Ltd noam@danenberg.co.il Contact Noam on LinkedIn Page3
Current as of January 2014 CURRICULUM VITAE NAME HALFON, Philippe, Ange, MD, PharmD, PhD, December 26, 1960, Married, 5 children President and founder of Alphabio Head of Infectious Diseases, Hospital Europeen, Marseille Fondateur of GENOSCIENCE PHARMA, Marseille MEDICAL EDUCATION PharmD from the University of Pharmacy of Marseille ( 1979-1984) Certificat d'etudes Supérieures d hématologie (1985) Certificat d'etudes Supérieures d Immunologie (1986) Certificat d'etudes Supérieures de Parasitologie-Mycologie (1987) Certificat d'etudes Supérieures de Batériologie Virologie (1987) Certificat d'etudes Supérieures de Pathologie Médicale ( 1988) Maitrise de Sciences (1989) Maitrise de Biologie cellulaire (1990) Maitrise de Biologie moléculaire (1991) Attestation Universitaire sur le SIDA (1992) PhD from the University of Luminy, Marseille ( 1996-1999) MD from the University of Medicine of Marseille(1999-2006) Research Director (HDR)From University of Medicine of Marseille ( 2003) Visiting Professor of Medicine, Emory University, Atlanta, Georgia, 2008 Infectious Diseases Specialist 2009 INTERNAL AND EXTERNAL TRAINING Resident in microbiology (1984-1987) Medical Center of the University Hospital of Marseilles, FR Junior Resident in Biology (1986-1987), Médaille d or des Hôpitaux (1988) Medical Center of the University Hospital of Marseilles, FR Senior Resident in Virology (1987-1988) Medical Center of the University Hospital of Marseilles, FR Fellow in Clinical Microbiology and Biochemistry (1989-1995) Fellow in Clinical Infectious Diseases of the University Hospital of Marseille, FR (2003-2007) Senior Resident in Infectious Diseases In Montreal, Canada (2001) FACULTY Enseignement en Maîtrise de Biologie Moléculaire (1987), Faculté de Médecine de Marseille Enseignement au DEA de Thérapie génique (1995), Marseille Enseignement au DU d hépatites virales (1997-2002), Faculté de Médecine de Marseille Enseignement au Master Recherche, spécialité oncologie : pharmacologie et thérapeutique Enseignement au DU on AIDS (2006), Faculté de Médecine de Marseille EXPERTISES Expert for French Recommendations of viral hepatitis 2014
Expert for French Consensus of Hepatitis C (2002) international Taxonomy organisation committee for HCV: Nomenclature and classification of HCV genotypes (2004) Expert for the French National Research on AIDS (ANRS) since 2005 Expert for the High Health Authority (Haute Autorité pour la santé ( HAS) since 2005 MEMBER OF INSTITUTIONNEL ASSOCIATION Member American Association for the Study of Liver Disease Member European Association for the Study of Liver Disease Member GEMHEP (Groupe d'études moléculaires des hépatites virales) Member of Association Française de l'etude du foie Member of Association Française de Recherche contre le SIDA Member of Association des praticiens de génétique moléculaire Peer Reviewer for international Journals More than 200 international publications ( see pubmed) Intellectual Property 3 Hold US Patens 1. US 61/487,226 : Non-competitive peptide-based HIV-1 pre-integration complex (PIC) inhibitors 2. PCT Patent Application No. PCT/IB2011/052762. TREATMENT OF HEPATITIS C VIRUS RELATED DISEASES USING HYDROXYCHLOROQUINE OR A COMBINATION OF HYDROXYCHLOROQUINE AND AN ANTI-VIRAL AGENT 3. 4347-117 PRV/PCT/US. NOVEL SPECIFIC HCV NS3 PROTEASE INHIBITORS